Oil & Gas Exploration & Production
Compare Stocks
5 / 10Stock Comparison
INDO vs HUSA vs TPVG vs AMPY vs CIVI
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Exploration & Production
Asset Management
Oil & Gas Exploration & Production
Oil & Gas Exploration & Production
INDO vs HUSA vs TPVG vs AMPY vs CIVI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Exploration & Production | Oil & Gas Exploration & Production | Asset Management | Oil & Gas Exploration & Production | Oil & Gas Exploration & Production |
| Market Cap | $47M | $80M | $243M | $221M | $2.34B |
| Revenue (TTM) | $4M | $379K | $97M | $263M | $4.71B |
| Net Income (TTM) | $-8M | $-11M | $-12M | $44M | $638M |
| Gross Margin | -10.7% | -69.0% | 83.5% | 93.2% | 43.9% |
| Operating Margin | -173.4% | -46.9% | 77.9% | 29.2% | 31.1% |
| Forward P/E | — | — | 6.5x | 20.1x | 6.8x |
| Total Debt | $882K | $71K | $469M | $3M | $4.49B |
| Cash & Equiv. | $5M | $3M | $20M | $61M | $76M |
INDO vs HUSA vs TPVG vs AMPY vs CIVI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Indonesia Energy Co… (INDO) | 100 | 81.1 | -18.9% |
| Houston American En… (HUSA) | 100 | 14.3 | -85.7% |
| TriplePoint Venture… (TPVG) | 100 | 59.8 | -40.2% |
| Amplify Energy Corp. (AMPY) | 100 | 493.6 | +393.6% |
| Civitas Resources, … (CIVI) | 100 | 160.3 | +60.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: INDO vs HUSA vs TPVG vs AMPY vs CIVI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
INDO lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, HUSA doesn't own a clear edge in any measured category.
TPVG carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 0.83, yield 17.1%
- Lower volatility, beta 0.83
- Lower P/E (6.5x vs 20.1x)
- 50.6% margin vs HUSA's -28.4%
AMPY is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 9.0% 10Y total return vs TPVG's 93.3%
- +101.9% vs HUSA's -64.0%
- 6.2% ROA vs INDO's -40.4%, ROIC 12.3% vs -31.5%
CIVI ranks third and is worth considering specifically for growth exposure and valuation efficiency.
- Rev growth 49.8%, EPS growth -6.2%, 3Y rev CAGR 77.5%
- PEG 0.32 vs TPVG's 6.41
- Beta 1.10, yield 18.2%, current ratio 0.45x
- 49.8% revenue growth vs HUSA's -29.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 49.8% revenue growth vs HUSA's -29.5% | |
| Value | Lower P/E (6.5x vs 20.1x) | |
| Quality / Margins | 50.6% margin vs HUSA's -28.4% | |
| Stability / Safety | Beta 0.83 vs CIVI's 1.10 | |
| Dividends | 18.2% yield, vs TPVG's 17.1%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +101.9% vs HUSA's -64.0% | |
| Efficiency (ROA) | 6.2% ROA vs INDO's -40.4%, ROIC 12.3% vs -31.5% |
INDO vs HUSA vs TPVG vs AMPY vs CIVI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
INDO vs HUSA vs TPVG vs AMPY vs CIVI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CIVI leads in 2 of 6 categories
AMPY leads 2 • INDO leads 0 • HUSA leads 0 • TPVG leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — TPVG and AMPY each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CIVI is the larger business by revenue, generating $4.7B annually — 12404.7x HUSA's $379,353. TPVG is the more profitable business, keeping 50.6% of every revenue dollar as net income compared to HUSA's -28.4%. On growth, INDO holds the edge at +45.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $4M | $379,353 | $97M | $263M | $4.7B |
| EBITDAEarnings before interest/tax | -$6M | -$18M | -$22M | $109M | $3.4B |
| Net IncomeAfter-tax profit | -$8M | -$11M | -$12M | $44M | $638M |
| Free Cash FlowCash after capex | -$6M | -$6M | $35M | -$13.5B | $934M |
| Gross MarginGross profit ÷ Revenue | -10.7% | -69.0% | +83.5% | +93.2% | +43.9% |
| Operating MarginEBIT ÷ Revenue | -173.4% | -46.9% | +77.9% | +29.2% | +31.1% |
| Net MarginNet income ÷ Revenue | -173.0% | -28.4% | +50.6% | +16.7% | +13.6% |
| FCF MarginFCF ÷ Revenue | -146.4% | -15.8% | -58.7% | -51.1% | +19.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +45.4% | -100.0% | — | -18.1% | -8.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -7.3% | -61.5% | -2.3% | +8394.1% | -33.9% |
Valuation Metrics
CIVI leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 3.2x trailing earnings, CIVI trades at a 39% valuation discount to AMPY's 5.3x P/E. Adjusting for growth (PEG ratio), CIVI offers better value at 0.15x vs TPVG's 4.84x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $47M | $80M | $243M | $221M | $2.3B |
| Enterprise ValueMkt cap + debt − cash | $43M | $77M | $691M | $163M | $6.8B |
| Trailing P/EPrice ÷ TTM EPS | -5.06x | -0.30x | 4.91x | 5.27x | 3.24x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 6.50x | 20.11x | 6.75x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 4.84x | — | 0.15x |
| EV / EBITDAEnterprise value multiple | — | — | 9.13x | 1.49x | 1.89x |
| Price / SalesMarket cap ÷ Revenue | 17.64x | 142.35x | 2.50x | 0.84x | 0.45x |
| Price / BookPrice ÷ Book value/share | 1.75x | 0.56x | 0.68x | 0.48x | 0.41x |
| Price / FCFMarket cap ÷ FCF | — | — | — | — | 2.61x |
Profitability & Efficiency
AMPY leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
AMPY delivers a 10.6% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-66 for HUSA. AMPY carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to TPVG's 1.33x. On the Piotroski fundamental quality scale (0–9), AMPY scores 7/9 vs HUSA's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -49.7% | -65.6% | -3.4% | +10.6% | +9.5% |
| ROA (TTM)Return on assets | -40.4% | -37.4% | -1.5% | +6.2% | +4.2% |
| ROICReturn on invested capital | -31.5% | -187.3% | +7.2% | +12.3% | +10.8% |
| ROCEReturn on capital employed | -32.9% | -128.4% | +9.4% | +12.6% | +12.1% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 | 5 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.05x | 0.02x | 1.33x | 0.01x | 0.68x |
| Net DebtTotal debt minus cash | -$4M | -$3M | $449M | -$58M | $4.4B |
| Cash & Equiv.Liquid assets | $5M | $3M | $20M | $61M | $76M |
| Total DebtShort + long-term debt | $881,639 | $71,082 | $469M | $3M | $4.5B |
| Interest CoverageEBIT ÷ Interest expense | — | — | -1.02x | — | 2.80x |
Total Returns (Dividends Reinvested)
AMPY leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AMPY five years ago would be worth $18,100 today (with dividends reinvested), compared to $1,342 for HUSA. Over the past 12 months, AMPY leads with a +101.9% total return vs HUSA's -64.0%. The 3-year compound annual growth rate (CAGR) favors TPVG at -1.2% vs HUSA's -54.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | 0.0% | — | -6.3% | +17.3% | -1.5% |
| 1-Year ReturnPast 12 months | +19.8% | -64.0% | +19.3% | +101.9% | +6.8% |
| 3-Year ReturnCumulative with dividends | -33.2% | -90.3% | -3.4% | -21.9% | -41.7% |
| 5-Year ReturnCumulative with dividends | -42.1% | -86.6% | -13.5% | +81.0% | +31.9% |
| 10-Year ReturnCumulative with dividends | -70.7% | -92.8% | +93.3% | +904.1% | -86.2% |
| CAGR (3Y)Annualised 3-year return | -12.6% | -54.1% | -1.2% | -7.9% | -16.5% |
Risk & Volatility
Evenly matched — INDO and AMPY each lead in 1 of 2 comparable metrics.
Risk & Volatility
INDO is the less volatile stock with a -2.13 beta — it tends to amplify market swings less than CIVI's 1.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMPY currently trades 80.0% from its 52-week high vs HUSA's 8.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -2.13x | -0.53x | 0.83x | -0.19x | 1.10x |
| 52-Week HighHighest price in past year | $8.50 | $25.56 | $7.53 | $6.79 | $37.45 |
| 52-Week LowLowest price in past year | $2.25 | $1.96 | $4.48 | $2.60 | $25.38 |
| % of 52W HighCurrent price vs 52-week peak | +36.9% | +8.5% | +79.5% | +80.0% | +73.1% |
| RSI (14)Momentum oscillator 0–100 | 42.4 | 22.9 | 58.3 | 41.4 | 54.8 |
| Avg Volume (50D)Average daily shares traded | 3.0M | 373K | 504K | 1.0M | 22.4M |
Analyst Outlook
CIVI leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: TPVG as "Hold", AMPY as "Buy", CIVI as "Hold". Consensus price targets imply 88.8% upside for AMPY (target: $10) vs 13.2% for CIVI (target: $31). For income investors, CIVI offers the higher dividend yield at 18.19% vs TPVG's 17.11%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | — | — | $8.95 | $10.25 | $31.00 |
| # AnalystsCovering analysts | — | — | 12 | 5 | 16 |
| Dividend YieldAnnual dividend ÷ price | — | — | +17.1% | — | +18.2% |
| Dividend StreakConsecutive years of raises | — | 0 | 0 | 0 | 0 |
| Dividend / ShareAnnual DPS | — | — | $1.02 | — | $4.98 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% | +18.3% |
CIVI leads in 2 of 6 categories (Valuation Metrics, Analyst Outlook). AMPY leads in 2 (Profitability & Efficiency, Total Returns). 2 tied.
INDO vs HUSA vs TPVG vs AMPY vs CIVI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is INDO or HUSA or TPVG or AMPY or CIVI a better buy right now?
For growth investors, Civitas Resources, Inc.
(CIVI) is the stronger pick with 49. 8% revenue growth year-over-year, versus -29. 5% for Houston American Energy Corp. (HUSA). Civitas Resources, Inc. (CIVI) offers the better valuation at 3. 2x trailing P/E (6. 8x forward), making it the more compelling value choice. Analysts rate Amplify Energy Corp. (AMPY) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — INDO or HUSA or TPVG or AMPY or CIVI?
On trailing P/E, Civitas Resources, Inc.
(CIVI) is the cheapest at 3. 2x versus Amplify Energy Corp. at 5. 3x. On forward P/E, TriplePoint Venture Growth BDC Corp. is actually cheaper at 6. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Civitas Resources, Inc. wins at 0. 32x versus TriplePoint Venture Growth BDC Corp. 's 6. 41x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — INDO or HUSA or TPVG or AMPY or CIVI?
Over the past 5 years, Amplify Energy Corp.
(AMPY) delivered a total return of +81. 0%, compared to -86. 6% for Houston American Energy Corp. (HUSA). Over 10 years, the gap is even starker: AMPY returned +904. 1% versus HUSA's -92. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — INDO or HUSA or TPVG or AMPY or CIVI?
By beta (market sensitivity over 5 years), Indonesia Energy Corporation Limited (INDO) is the lower-risk stock at -2.
13β versus Civitas Resources, Inc. 's 1. 10β — meaning CIVI is approximately -151% more volatile than INDO relative to the S&P 500. On balance sheet safety, Amplify Energy Corp. (AMPY) carries a lower debt/equity ratio of 1% versus 133% for TriplePoint Venture Growth BDC Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — INDO or HUSA or TPVG or AMPY or CIVI?
By revenue growth (latest reported year), Civitas Resources, Inc.
(CIVI) is pulling ahead at 49. 8% versus -29. 5% for Houston American Energy Corp. (HUSA). On earnings-per-share growth, the picture is similar: Amplify Energy Corp. grew EPS 232. 3% year-over-year, compared to -145. 0% for Houston American Energy Corp.. Over a 3-year CAGR, CIVI leads at 77. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — INDO or HUSA or TPVG or AMPY or CIVI?
TriplePoint Venture Growth BDC Corp.
(TPVG) is the more profitable company, earning 50. 6% net margin versus -1466. 7% for Houston American Energy Corp. — meaning it keeps 50. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TPVG leads at 77. 9% versus -1649. 6% for HUSA. At the gross margin level — before operating expenses — AMPY leads at 93. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is INDO or HUSA or TPVG or AMPY or CIVI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Civitas Resources, Inc. (CIVI) is the more undervalued stock at a PEG of 0. 32x versus TriplePoint Venture Growth BDC Corp. 's 6. 41x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, TriplePoint Venture Growth BDC Corp. (TPVG) trades at 6. 5x forward P/E versus 20. 1x for Amplify Energy Corp. — 13. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMPY: 88. 8% to $10. 25.
08Which pays a better dividend — INDO or HUSA or TPVG or AMPY or CIVI?
In this comparison, CIVI (18.
2% yield), TPVG (17. 1% yield) pay a dividend. INDO, HUSA, AMPY do not pay a meaningful dividend and should not be held primarily for income.
09Is INDO or HUSA or TPVG or AMPY or CIVI better for a retirement portfolio?
For long-horizon retirement investors, Indonesia Energy Corporation Limited (INDO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -2.
13)). Both have compounded well over 10 years (INDO: -70. 7%, CIVI: -86. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between INDO and HUSA and TPVG and AMPY and CIVI?
These companies operate in different sectors (INDO (Energy) and HUSA (Energy) and TPVG (Financial Services) and AMPY (Energy) and CIVI (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: INDO is a small-cap quality compounder stock; HUSA is a small-cap quality compounder stock; TPVG is a small-cap high-growth stock; AMPY is a small-cap deep-value stock; CIVI is a small-cap high-growth stock. TPVG, CIVI pay a dividend while INDO, HUSA, AMPY do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.